We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Health Catalyst has also granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering